Patent Dimensions in the Development and Production of COVID-19 Vaccines
Abstract The process in which COVID-19 vaccines are developed is sequential and continuously accumulating. On the one hand, comprehensive patent protection is a necessary means to promote research and development. It yields additional returns that pay for the occasionally substantial amounts in R&am...
Saved in:
Main Authors: | Tobias Volpert, Marcel Riepe |
---|---|
Format: | Article |
Language: | deu |
Published: |
Sciendo
2021-05-01
|
Series: | Wirtschaftsdienst |
Online Access: | https://doi.org/10.1007/s10273-021-2923-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficiency enhancement in main path extraction in mRNA vaccine field: A novel approach leveraging intermediate patents, with shielding origin and terminus patent edges
by: Ting Zhang, et al.
Published: (2025-12-01) -
A Case of TAFRO Syndrome Developed after COVID-19 Vaccination
by: Hitomi Hirose, et al.
Published: (2023-01-01) -
Menstrual Changes after COVID-19 Infection and COVID-19 Vaccination
by: Işılay Taşkaldıran, et al.
Published: (2022-01-01) -
MARKETING STRATEGIES DEVELOPMENT APPROACHES FOR MANAGING PATENT PORTFOLIOS
by: R. Tokarev
Published: (2017-07-01) -
The Psychological Benefits of COVID-19 Vaccination
by: My Nguyen
Published: (2021-01-01)